Enliven Therapeutics, Inc. — Institutional Ownership

Which tracked institutions hold ELVN, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.

18
Funds holding
$257101954
Total value held
Buying
17 added/new · 0 reduced
# Institution Value Shares Δ Shares Change (QoQ)
1 Blackrock, Inc. $144440514 3684707 +71381 +1.98%
2 State Street Corp $42771355 1091106 +38244 +3.63%
3 Morgan Stanley $20328037 518572 +106749 +25.92%
4 Goldman Sachs Group Inc $18546108 473115 +235911 +99.45%
5 Northern Trust Corp $14594788 372316 +20077 +5.70%
6 Ameriprise Financial Inc $6294619 160577 +141628 +747.42%
7 Bank Of New York Mellon Corp $4706235 120057 +9488 +8.58%
8 Bank Of America Corp /De/ $1770351 45162 +12451 +38.06%
9 Franklin Resources Inc $791134 20182 +15 +0.07%
10 Wells Fargo & Company/Mn $663062 43056 +17232 +66.73%
11 Barclays Plc $463735 11830 NEW BUY
12 Janus Henderson Group Plc $431200 11000 NEW BUY
13 Raymond James Financial Inc $415990 10612 NEW BUY
14 Invesco Ltd. $380688 24720 +1624 +7.03%
15 Citigroup Inc $284730 18489 +6743 +57.41%
16 Royal Bank Of Canada $212000 5424 NEW BUY
17 Us Bancorp \De\ $6546 167 NEW BUY
18 Pnc Financial Services Group, Inc. $862 22 Held

Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.